FactorPad
Build a Better Process

Stock Risk Measures for Veracyte Inc

A quantitative factor review as of June 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: July 06, 2021
See how we arrive at an overall risk score of 78 for VCYT below.

/ factorpad.com / stocks / f83qdv.html


An ad-free and cookie-free website.


VCYT Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Veracyte Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how VCYT stock compares to 2,000+ US-based stocks, and to peers in the Health Care and Social Assistance sector and Medical Laboratories industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company's growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company's tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development. With Veracyte's exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f83qdv.html


VCYT stock risk
VERACYTE INC stock beta
VCYT risk report
VCYT f83qdv
VCYT risk analysis
VCYT volatility
VERACYTE INC credit risk
VCYT liquidity risk
VCYT leverage
VCYT valuation
VCYT systematic risk
VCYT specific risk
VERACYTE INC volatility
VCYT analysis
VCYT financial ratio

A newly-updated free resource. Connect and refer a friend today.